For research use only. Not for therapeutic Use.
SJ10542（Cat No.:I044140）is a selective inhibitor of mutant isocitrate dehydrogenase 1 (IDH1), an enzyme implicated in various cancers, including gliomas and acute myeloid leukemia (AML). Mutant IDH1 produces the oncometabolite 2-hydroxyglutarate (2-HG), which disrupts epigenetic regulation and cellular differentiation. SJ10542 effectively reduces 2-HG levels, restoring normal cellular function and differentiation. It is used in preclinical studies to investigate the role of mutant IDH1 in tumorigenesis and assess the therapeutic potential of IDH1-targeted treatments. SJ10542 serves as a valuable tool in cancer metabolism and epigenetics research focused on IDH1-mutant malignancies.
| CAS Number | 2789678-92-6 |
| Synonyms | 4-[[4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-N-[3-[4-[4-(2,6-dioxopiperidin-3-yl)phenyl]piperazin-1-yl]propyl]benzamide |
| Molecular Formula | C41H46N12O5S |
| Purity | ≥95% |
| IUPAC Name | 4-[[4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-N-[3-[4-[4-(2,6-dioxopiperidin-3-yl)phenyl]piperazin-1-yl]propyl]benzamide |
| InChI | InChI=1S/C41H46N12O5S/c1-2-59(57,58)52-26-41(27-52,15-16-42)53-25-30(24-45-53)36-34-14-18-43-37(34)49-40(48-36)46-31-8-4-29(5-9-31)38(55)44-17-3-19-50-20-22-51(23-21-50)32-10-6-28(7-11-32)33-12-13-35(54)47-39(33)56/h4-11,14,18,24-25,33H,2-3,12-13,15,17,19-23,26-27H2,1H3,(H,44,55)(H,47,54,56)(H2,43,46,48,49) |
| InChIKey | WBEBZVDAHMXWJN-UHFFFAOYSA-N |
| SMILES | CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC(=N3)NC5=CC=C(C=C5)C(=O)NCCCN6CCN(CC6)C7=CC=C(C=C7)C8CCC(=O)NC8=O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
